[Surfactant replacement therapy increases life-span of patients with acute respiratory distress syndrome].
Klin Khir
; (2): 57-9, 2013 Feb.
Article
en Ru
| MEDLINE
| ID: mdl-23705485
ABSTRACT
The aim of the study is the evaluation of the influence of surfactant replacement therapy on the life-span of patients with acute respiratory distress syndrome (ARDS) in fatal cases. It has been determined, that in patients, were died from ARDS, exogenous surfactant therapy increases life-span from the moment of establishing of diagnosis of syndrome to fatal outcome. The initial functional state of lungs does not influence on life-span of patients with ARDS, but administration of exogenous surfactant is the important predictor of its increase.
Buscar en Google
Base de datos:
MEDLINE
Asunto principal:
Síndrome de Dificultad Respiratoria
/
Surfactantes Pulmonares
/
Pulmón
Tipo de estudio:
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Límite:
Adult
/
Female
/
Humans
/
Male
/
Middle aged
Idioma:
Ru
Revista:
Klin Khir
Año:
2013
Tipo del documento:
Article